Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xuehua Lin
Observed name:
Lin, Xuehua
Institutions:
Royal College of Surgeons in Ireland,
Trinity College Dublin,
Soochow University,
First Affiliated Hospital of Soochow University
Observed institutions:
Royal College of Surgeons in Ireland,
Jinan University,
Trinity College Dublin,
Soochow University,
Zhuhai People's Hospital,
First Affiliated Hospital of Soochow University
show all 6
ORCID:
0009-0006-5687-3195
Observed ORCID:
0009-0006-5687-3195
OpenAlex ID:
A5082338603
Significance of KDM6A mutation in bladder cancer immune escape
2021
·
Xingxing Chen
, Xuehua Lin
, et al.
·
BMC Cancer
·
49
PDF
A bioinspired doxorubicin-carried albumin Nanocage against aggressive Cancer via systemic targeting of tumor and lymph node metastasis
2024
·
Haroon Iqbal
, Anam Razzaq
, et al.
·
Journal of Controlled Release
·
30
[Retracted] HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan‐Cancer
2022
·
Zeng Yang
, Diao Xu
, et al.
·
BioMed Research International
·
13
PDF
Photo-responsive polyprodrug supramolecular assemblies with self-accelerated subcellular delivery for synergistic photochemotherapy
2026
·
Ming Liu
, Zhenduo Zhao
, et al.
·
中国科学通报:英文版
·
5
Enhancing cancer radiotherapy efficacy using NanOx, a novel oxygenating perfluorocarbon nanoemulsion that reverses tumour hypoxia
2024
·
Maitiú Ó Murchú
, Xuehua Lin
, et al.
·
Cancer Letters
·
5
Feasibility study of expressing epcam + /vimentin + CTC in prostate cancer diagnosis
2023
·
Junyong Chen
, Tao Xie
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
4
PDF
A coordination-assembled ferric nanoenzyme enables spatiotemporal radical storm for amplifying chemodynamic immunotherapy
2026
·
Ting Li
, Xuehua Lin
, et al.
·
Journal of Controlled Release
Tumour hypoxia in clinical oncology: imaging, therapeutic strategies, and translational challenges
2026
·
Xuehua Lin
, Maitiú Ó. Murchú
, et al.
·
Clinical and Translational Radiation Oncology
PDF
Abstract C100: Therapeutic targeting of microRNA-31 promotes chemosensitivity via ATOX1 in pancreatic ductal adenocarcinoma
2025
·
David Hackett
, Jason McGrath
, et al.
·
Molecular Cancer Therapeutics
Show more works
View as search
Works count:
11
Citation count:
106
H-index:
5
I10-index:
3
Year
Topic
Type